Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (monocyte progenitors) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 5 Parkinson's papers of 13,452 | 0.76 |
| pathways Reactome | 14 pathways; mostly dopamine synapse | 1.00 |
No case: the score is under the bar. Receipt 14569
Sealed predictions
- BRCA2 in dopamine neurons, braak+0.17 (p 0.663) → +0.69 (p 0.040)receipt 14576
Swarm cases
receipt 14576: BRCA2 in dopamine neurons, braak
- power
- full sample +0.35 (p 0.159, n 18), 95% CI -0.14 to +0.70. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.42 (p 0.080, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.42 (p 0.080, n 18). could be the mix.
- skeptic
- leave-one-out range +0.28 to +0.52, sign flips 0; without severely affected donors +0.35 (p 0.159, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for BRCA2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts